risk of edema, fractures, bladder cancer Non-Insulin Injectable Agents (assign Z79.85): GLP-1 receptor agonists (semaglutide, liraglutide, dulaglutide, tirzepatide [dual GIP/GLP-1]): Cardiovascular and renal protective
doi: 10.1016/j.metabol.2024.155998
Medical necessity narrative (if requested): For payers that require prior authorization or post-service review, a brief clinical summary explaining why oral supplementation is not appropriate may be required
When stacked intelligently with supportive supplements like DHEA, ZMT, or peptides like Tesamorelin and BPC-157 5-Amino-1MQ becomes a powerful asset for body recomposition and longevity optimization
Otherwise, theyre very similar fillers
doi: 10.1530/acta.0.1280313 143 MeinhardtUNelsonAEHansenJLBirznieceVCliffordDLeungKCet al